about
A review of the second-generation antihistamine ebastine for the treatment of allergic disordersEffects of supratherapeutic doses of ebastine and terfenadine on the QT intervalComparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute UrticariaCardiovascular safety of antihistamines.Antihistamines in late-phase clinical development for allergic disease.Ebastine in the light of CONGA recommendations for the development of third-generation antihistaminesEbastine in chronic spontaneous urticaria in higher dosesAcquired cold urticaria symptoms can be safely prevented by ebastine.Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis.Itraconazole and rifampin alter significantly the disposition and antihistamine effect of ebastine and its metabolites in healthy participants.Duration of the antihistaminic effect after discontinuation of ebastine.A Critical Review of Physicochemical Properties and Analytical Methods Applied to Quantitative Determination of Ebastine.
P2860
Q28272998-5C417A01-BFB7-42F4-A998-DE96F5770F2DQ28345558-BB6F9687-9663-4369-ABA7-B6150E98E71AQ33666953-08607CED-270C-4DE3-AAE6-2889583D969EQ33955706-5A9E99B0-7CA8-49C0-A9F8-969AC1EBBB83Q34519151-C7A6A02C-08AF-4296-AF3C-D5B711389A40Q34623813-7310514F-801F-4631-8582-A3AA313850E2Q34633950-3D0ACD34-61EF-40EB-9D8C-99D118BC6A4AQ34694547-EE1F305B-F8AD-49C7-AAFD-F5E12368FC2EQ40065010-683C6AA2-1E3D-4200-8BDC-9C8441F0C389Q43258643-6359F408-AA97-46F0-B31A-B6D471E41F01Q43650414-6BC0CEA4-7D21-44C7-81F3-01AA8A55B985Q47918306-F441178B-9FE1-4B21-B07F-A47346F40DB6
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ebastine: an update of its use in allergic disorders.
@ast
Ebastine: an update of its use in allergic disorders.
@en
type
label
Ebastine: an update of its use in allergic disorders.
@ast
Ebastine: an update of its use in allergic disorders.
@en
prefLabel
Ebastine: an update of its use in allergic disorders.
@ast
Ebastine: an update of its use in allergic disorders.
@en
P1433
P1476
Ebastine: an update of its use in allergic disorders.
@en
P2093
P304
P356
10.2165/00003495-200059040-00018
P577
2000-04-01T00:00:00Z
P6179
1047975560